Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01831739 · ClinicalTrials.gov registry record

Genomic Research in Sarcoidosis

A clinical trial, sponsored by University of Pittsburgh.

Completed
Registry status
368
Enrollment target

NCT01831739: Completed study, sponsored by University of Pittsburgh.

NCT01831739 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 368 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01831739 has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
368 participants
Enrollment target

Study Summary

This project is designed to address the following hypothesis: Distinct patterns in lung microbiome are characteristic of sarcoidosis phenotypes and reflected in changes in systemic inflammatory responses as measured by peripheral changes in gene transcription. The Specific Aims are: 1. To identify peripheral blood mononuclear cell (PBMC) gene expression patterns that characterize distinct sarcoidosis phenotypes. 2. To determine whether patterns in the lung microbiome are associated with sarcoidosis severity and disease phenotypes 3. To correlate mRNA and microRNA expression patterns in sarcoidosis affected organs with changes in microbiome, clinical parameters and PBMC gene expression patterns 4. To integrate clinical, transcriptomic, and microbiome data to identify novel molecular phenotypes in sarcoidosis.

Primary Outcome

To identify peripheral blood mononuclear cell (PBMC) gene expression patterns that characterize distinct sarcoidosis phenotypes, samples will be run in batches in block designs (equal numbers of phenotypes) and batches will be analyzed independently to determine reproducibility - a subset of samples will be rerun to assure continuity and established normalization algorithms will be applied 1-3. Normalized human transcript (mRNA and microRNA) levels obtained from PBMC will be related to establish

Trial Details

FieldValue
Enrollment Target 368 participants
Start Date 2013-05
Est. Completion 2015-09
University of Pittsburgh

1,238 total trials

What the finished NCT01831739 record still lists

NCT01831739 is an observational study that tracks outcomes without assigning an intervention. The registered 368 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01831739 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01831739 about?

NCT01831739 is a clinical study titled "Genomic Research in Sarcoidosis". This project is designed to address the following hypothesis: Distinct patterns in lung microbiome are characteristic of sarcoidosis phenotypes and reflected in changes in systemic inflammatory responses as measured by peripheral changes in gene transcription. The Specific Aims are: 1. To identif...

What is the current status of trial NCT01831739?

This trial is currently completed. The enrollment target is 368 participants. The study started on 2013-05. Estimated completion is 2015-09.

Who is sponsoring clinical trial NCT01831739?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04675476 · 368 participants · NA

    A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening

  • NCT05215353 · 368 participants · Phase 4

    A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors

  • NCT06182397 · 368 participants · NA

    Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease

  • NCT06629610 · 368 participants · NA

    Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01831739, the US trial registry maintained by the National Library of Medicine. NCT01831739 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.